D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder

Biological Psychiatry

Volumn 62, Issue 8, 2007, Pages 835-838

  Kushner, Matt G ^a   Kim, Suck Won ^a   Donahue, Christopher ^a   Thuras, Paul ^a   Adson, David ^a   Kotlyar, Michael ^a   McCabe, James ^a   Peterson, Jillian ^a   Foa, Edna B ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cognitive behavioral therapy; D cycloserine; obsessive compulsive disorder; treatment

Indexed keywords

CYCLOSERINE;

ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; CYCLOSERINE; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID AGONISTS; EXTINCTION, PSYCHOLOGICAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PATIENT COMPLIANCE; PATIENT DROPOUTS; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME;

EID: 34548313337     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.12.020     Document Type: Article

References (14)

1. Botreau F., Paolone G., and Stewart J. D-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav Brain Res 172 1 (2006) 173-178
2. First M.B., Spitzer R., Gibbon M., and Williams J. Structural Clinical Interview for Axis-I DSM-IV Disorders, Patient Edition (SCID-I/P Version 2.0) (1989), Biometrics Research Department, New York State Psychiatric Institute, New York
3. Goodman W., Price L., Rasmussen S., and Mazure C. The Yale-Brown Obsessive-Compulsive Scale I: Development, use and reliability. Arch Gen Psychiatry 46 (1989) 1006-1011
4. Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R (in press): A randomized controlled trial of the effect of D-Cycloserine on exposure therapy for spider fear. J Psychiatr Res.
5. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., et al. Augmentation of exposure therapy with D-Cycloserine for social anxiety disorder. Arch Gen Psychiatry 63 (2006) 298-304
6. Ledgerwood L., Richardson R., and Cranney J. D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biol Psychiatry 57 8 (2005) 841-847
7. Miller R.F. D-Serine as a glial modulator of nerve cells. Glia 47 3 (2004) 275-283
8. Quartermain D., Mower J., Rafferty M.F., Herting R.L., and Lanthorn T.H. Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol 257 1-2 (1994) 7-12
9. Rauch S.L., Savage C.R., Alpert N.M., Fischman A.J., and Jenike M.A. The functional anatomy of anxiety: A study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 42 (1997) 446-452
10. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobics to facilitate extinction of fear. Arch Gen Psychiatry 61 (2004) 1136-1144
11. Richardson R., Ledgerwood L., and Cranney J. Facilitation of fear extinction by D-cycloserine: Theoretical and clinical implications. Learn Mem 11 (2004) 510-516
12. Riggs D.S., and Foa E.B. Obsessive-compulsive disorder. In: Barlow D.H. (Ed). Clinical Handbook of Psychological Disorders (1993), Guilford Press, New York 189-239
13. Walker D.L., Ressler K.J., Lu K.T., and Davis M. Facilitation of conditioned fear extinction by systemic administration of intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22 (2002) 2343-2351
14. Watanabe Y., Saito H., and Abe K. Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices. Eur J Pharmacol 223 (1992) 179-184